Gene Symbol | HOXA1 |
---|---|
Entrez Gene | 3198 |
Alt Symbol | BSAS, HOX1, HOX1F |
Species | Human |
Gene Type | protein-coding |
Description | homeobox A1 |
Other Description | HOX A1 homeodomain protein|Hox 1.6-like protein|homeo box A1|homeobox 1F|homeobox protein Hox-1F|homeobox protein Hox-A1|lab-like protein |
Swissprots | O43363 B2R8U7 A4D184 P49639 |
Accessions | AAS00374 CAR95136 CAR95137 EAL24228 EAL24229 EAW93861 EAW93862 P49639 AK308067 AK313514 BAG36294 BC032547 AAH32547 DB246535 DQ890884 ABM81810 DQ894038 ABM84964 S79869 AAB35424 S79871 AAB35425 S79910 AAB35423 U10421 AAA86954 U37431 AAC50248 NM_005522 NP_005513 NM_153620 NP_705873 |
Function | Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Acts on the anterior body structures. Seems to act in the maintenance and/or generation of hindbrain segments. |
Subcellular Location | Nucleus. |
HOXA1-Over-expression-Lysate - LY12730a from Abgent, a WuXi AppTec company
|
||||||||
HOXA1 293T Cell Transient Overexpression Lysate(Denatured) - H00003198-T01 from Acris Antibodies
|
||||||||
HOXA1 overexpression lysate - LY406991 from Acris Antibodies
|
||||||||
HOXA1 overexpression lysate - LY417249 from Acris Antibodies
|
||||||||
HOXA1 overexpression lysate - LY429253 from Acris Antibodies
|
||||||||
HOXA1 293 Cell Lysate - 404083 from ABBIOTEC
|
||||||||
HOXA1 Overexpression Lysate (Denatured) - H00003198-T01 from Novus Biologicals
|
||||||||
HOXA1 Overexpression Lysate (Native) - NBP2-05236 from Novus Biologicals
|
||||||||
HoxA1 (h): 293T Lysate - sc-115272 from Santa Cruz Biotechnology
|
||||||||
HOXA1 Over-expression Lysate Product - GWB-9AF889 from Genway Biotech
|
||||||||
HOXA1 Overexpression Lysate (Native) - NBP2-09817 from Novus Biologicals
|
||||||||
HOXA1 Overexpression Lysate (Native) - NBP2-07737 from Novus Biologicals
|
||||||||
Panoply™ Human HOXA1 Knockdown Stable Cell Line - CSC-DC007182 from Creative biogene
|
||||||||